How Safe is Gadolinium in Paediatric MRIs?
Gadolinium-based contrast agents (GBCAs) are an indispensable part of clinical diagnostic and therapeutic decision making for millions of patients worldwide. Notwithstanding the excellent safety profile of GBCAs, the finding by Kanda et al of signal intensity increase in brain structures after the administration of GBCAs started a new safety debate on the potential risks of gadolinium deposition in the brain.
Modern Medicine – April/May 2019
